HSCA Statement for the Record on the House Ways & Means Committee’s February 6, 2024 Hearing on Drug Shortages
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading
healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide a
statement for the record regarding the February 6, 2024, hearing examining chronic drug shortages in
the United States.
Click here to read the full response.
Lear MoreHSCA Comments to Senate Committee on Health, Labor, Education, and Pensions on Senator Cassidy’s Gene Therapy Request for Information (RFI)
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide our responses to your request for information on improving access to gene therapies.
Click here to view the full response.
Lear MoreHSCA Statement for the Record on the Senate Finance Committee’s December 5, 2023, Hearing on Drug Shortages
On behalf of the Healthcare Supply Chain Association (HCSA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide a statement for the record regarding the December 5, 2023, hearing on examining supply challenges, impacts, and policy solutions for drug shortages.
Click here to read the full response.
Lear MoreHSCA Comments to the Senate Committee on Homeland Security and Governmental Affairs (HSGAC)’s Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments on “The Rolling Active Pharmaceutical Ingredient and Drug (RAPID) Reserve Act” (S.2510).
Click here to view the full response.
Lear MoreHSCA Comments to Energy & Commerce Committee’s Stop Drug Shortages Act Discussion Draft
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the Energy & Commerce Committee’s Stop Drug Shortages Act Discussion Draft.
Click here to read the full response.
Lear More
HSCA Response to Congressional Drug Shortages Request for Information (RFI)
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the joint committee drug shortages request for information (RFI).
Click here to read the full response.
Lear More
HSCA Response to Senate Committee on Health, Education, Labor, and Pensions (HELP) RFI on the Pandemic and All-Hazards Preparedness Act (PAHPA)
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading
healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide the Senate
Health, Education, Labor, and Pensions (HELP) Committee with our recommendations on the
reauthorization of the Pandemic and All-Hazards Preparedness (PAHPA) Act.
Click here to read the full response.
Lear MoreHSCA Response to Congressional RFI on the Pandemic and All-Hazards Preparedness Act (PAHPA)
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to comment on the Pandemic and All-Hazards Preparedness Act (PAHPA) programs and authorities.
Click here to read the full response.
Lear MoreHSCA Support Letter to the House Committee on Energy & Commerce on House Passage of FDA User Fee Reauthorizations
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we applaud the bipartisan leadership of Chairman Pallone, Chairwoman Eshoo, Ranking Member Rodgers, and Ranking Member Guthrie of the House Committee on Energy & Commerce on the Food and Drug Amendments Act of 2022, which the House of Representatives recently passed with overwhelming support by a vote of 392-28. Timely access to safe and effective drugs, devices, products, and biologics for all Americans is of critical importance to GPOs, which serve as the sourcing partners to virtually all hospitals, clinics, ambulatory surgery centers, and long-term care facilities.
Click here to read the full letter.
Lear MoreHSCA Comments to the Senate Committee on Health, Education, Labor, and Pensions on the PREVENT Pandemics Act
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), we appreciate the opportunity to comment on the Committee’s draft text of the ‘Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act’ (PREVENT Pandemics Act).
Click here to read the full comments.
Lear More